Atelerix is a preclinical biotech company developing a platform technology of novel small molecules targeting unmet medical needs arising from the opioid crisis.

Post surgery respiratory depression

Opioid weaponization / use in terrorism

Addiction / overdose / tolerance / GI motility / withdrawal